Seed · Healthtech
Corologic receives seed financing for clinical validation
Corologic received an undisclosed seed investment from Kakao Ventures and Seoul National University Technology Holdings in September.
The company plans multicenter clinical validation, regulatory submissions in South Korea and the United States, and ISO 13485 quality certification.
The funding advances Angio-FILM, which reconstructs intermediate coronary angiography frames to support visualization from fewer X-ray images.
Use of funds
Pursue multicenter clinical validation
Seek 510(k) approvals from South Korea's Ministry of Food and Drug Safety and the U.S. FDA
Obtain ISO 13485 quality certification
Funding history
Seed · This roundUndisclosed